Bnp Paribas Arbitrage, Snc »

Kazia Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Kazia Therapeutics (KZIA) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Kazia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kazia Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kazia Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.0k 1.1k 7.44

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
State Street SPDR S&P Biotech ETF Fund (XBI)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
JPMorgan Chase & Co Equity (JPM)
Meta Platforms Equity (META)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Micron Technology Equity (MU)
iShares Russell 2000 ETF Fund (IWM)
Oracle Corp Equity (ORCL)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Kazia Therapeutics

Stonepine Capital Management
Bleichroeder
Velan Capital Investment Management
Point72 Asset Management
Balyasny Asset Management
Putnam Fl Investment Management
Sequoia Financial Advisors
Westside Investment Management
Royal Bank of Canada
Barclays
UBS Group
Rockefeller Capital Management
Engineers Gate Manager
FNY Investment Advisers
GAMMA Investing

View all funds holding Kazia Therapeutics